Ruthenium complex with benznidazole and nitric oxide as a new candidate for the treatment of Chagas disease (2014)
- Authors:
- USP affiliated authors: MILANEZI, CRISTIANE MARIA - FMRP ; SILVA, ROBERTO SANTANA DA - FCFRP ; SILVA, JOÃO SANTANA DA - FMRP
- Unidades: FMRP; FCFRP
- DOI: 10.1371/journal.pntd.0003207
- Subjects: DOENÇA DE CHAGAS (TERAPIA); FARMACOLOGIA; RUTÊNIO; ÓXIDO NÍTRICO
- Language: Inglês
- Imprenta:
- Publisher place: San Francisco
- Date published: 2014
- Source:
- Título do periódico: PLOS Neglected Tropical Diseases
- ISSN: 1935-2735
- Volume/Número/Paginação/Ano: v. 8, n. 10, art. e3207, 2014
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
SESTI-COSTA, Renata et al. Ruthenium complex with benznidazole and nitric oxide as a new candidate for the treatment of Chagas disease. PLOS Neglected Tropical Diseases, v. 8, n. 10, 2014Tradução . . Disponível em: https://doi.org/10.1371/journal.pntd.0003207. Acesso em: 23 abr. 2024. -
APA
Sesti-Costa, R., Carneiro, Z. A., Silva, M. C., Santos, M., Silva, G. K. da, Milanezi, C. M., et al. (2014). Ruthenium complex with benznidazole and nitric oxide as a new candidate for the treatment of Chagas disease. PLOS Neglected Tropical Diseases, 8( 10). doi:10.1371/journal.pntd.0003207 -
NLM
Sesti-Costa R, Carneiro ZA, Silva MC, Santos M, Silva GK da, Milanezi CM, Silva RS da, Silva JS da. Ruthenium complex with benznidazole and nitric oxide as a new candidate for the treatment of Chagas disease [Internet]. PLOS Neglected Tropical Diseases. 2014 ; 8( 10):[citado 2024 abr. 23 ] Available from: https://doi.org/10.1371/journal.pntd.0003207 -
Vancouver
Sesti-Costa R, Carneiro ZA, Silva MC, Santos M, Silva GK da, Milanezi CM, Silva RS da, Silva JS da. Ruthenium complex with benznidazole and nitric oxide as a new candidate for the treatment of Chagas disease [Internet]. PLOS Neglected Tropical Diseases. 2014 ; 8( 10):[citado 2024 abr. 23 ] Available from: https://doi.org/10.1371/journal.pntd.0003207 - Doxycycline and benznidazole reduce the profile of Th1, Th2, and Th17 chemokines and chemokine receptors in cardiac tissue from chronic Trypanosoma cruzi-infected dogs
- CCR2 receptor is essential to activate microbicidal mechanisms to control Toxoplasma gondii infection in the central nervous system
- Th17-inducing cytokines IL-6 and IL-23 are crucial for granuloma formation during experimental Paracoccidioidomycosis
- Toxoplasma gondii: the severity of toxoplasmic encephalitis in C57BL/6 mice is associated with increased ALCAM and VCAM-1 expression in the central nervous system and higher blood-brain barrier permeability
- Heme oxygenase-1 activity is involved in the control of Toxoplasma gondii infection in the lung of BALB/c and C57BL/6 and in the small intestine of C57BL/6 mice
- Tr-1-like CD4+CD25-CD127-/lowFOXP3-cells are the main source of interleukin 10 in patients with cutaneous leishmaniasis due to Leishmania braziliensis
- IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis
- Aspectos químicos e atividade biológica do complexo nitrosilo de rutênio coordenado ao benznidazol contra Trypanosoma cruzi
- IL-18 triggered by the Nlrp3 inflammasome induces host innate resistance in a pulmonary model of fungal infection
- NLRC4 inhibits NLRP3 inflammasome and abrogates effective antifungal CD8 + T cell responses
Informações sobre o DOI: 10.1371/journal.pntd.0003207 (Fonte: oaDOI API)
Download do texto completo
Tipo | Nome | Link | |
---|---|---|---|
002702314.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas